Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Fuchs

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Biorxiv : the Preprint Server for Biology|December 12, 2025
HTS-Oracle: Experimentally validated AI-enabled prioritization for generalizable small molecule hit discoveryHossam Nada, Laura Calvo-Barreiro, Natalie Fuchs, et al.
European Journal of Medicinal Chemistry|May 21, 2022
New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsinsSascha Jung, Natalie Fuchs, Christoph Grathwol, et al.
ACS Infectious Diseases|April 30, 2024
Dual Strategy to Design New Agents Targeting <i>Schistosoma mansoni</i>: Advancing Phenotypic and <i>Sm</i>CB1 Inhibitors for Improved EfficacyNatalie Fuchs, Robert A Zimmermann, Marvin Schwickert, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 14, 2023
Next Generation of Fluorometric Protease Assays: 7-Nitrobenz-2-oxa-1,3-diazol-4-yl-amides (NBD-Amides) as Class-Spanning Protease SubstratesHannah Maus, Patrick Müller, Mergim Meta, et al.
ACS Chemical Biology|March 9, 2022
Identification, Characterization, and Synthesis of Natural Parasitic Cysteine Protease Inhibitors: Pentacitidins Are More Potent Falcitidin AnaloguesStephan Brinkmann, Sandra Semmler, Christian Kersten, et al.
Journal of Medicinal Chemistry|August 11, 2021
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo StudiesSascha Jung, Natalie Fuchs, Patrick Johe, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biorxiv : the Preprint Server for Biology|December 12, 2025
HTS-Oracle: Experimentally validated AI-enabled prioritization for generalizable small molecule hit discoveryHossam Nada, Laura Calvo-Barreiro, Natalie Fuchs, et al.
European Journal of Medicinal Chemistry|May 21, 2022
New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsinsSascha Jung, Natalie Fuchs, Christoph Grathwol, et al.
ACS Infectious Diseases|April 30, 2024
Dual Strategy to Design New Agents Targeting <i>Schistosoma mansoni</i>: Advancing Phenotypic and <i>Sm</i>CB1 Inhibitors for Improved EfficacyNatalie Fuchs, Robert A Zimmermann, Marvin Schwickert, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 14, 2023
Next Generation of Fluorometric Protease Assays: 7-Nitrobenz-2-oxa-1,3-diazol-4-yl-amides (NBD-Amides) as Class-Spanning Protease SubstratesHannah Maus, Patrick Müller, Mergim Meta, et al.
ACS Chemical Biology|March 9, 2022
Identification, Characterization, and Synthesis of Natural Parasitic Cysteine Protease Inhibitors: Pentacitidins Are More Potent Falcitidin AnaloguesStephan Brinkmann, Sandra Semmler, Christian Kersten, et al.
Journal of Medicinal Chemistry|August 11, 2021
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo StudiesSascha Jung, Natalie Fuchs, Patrick Johe, et al.
Pageof 2